welcome 

 

We are very excited to announce that the next 18th St.Gallen International Breast Cancer Conference 2023 will take place from 15 – 18 March 2023 in Vienna/ Austria.

Experts and literally all major breast cancer cooperative groups and centres worldwide, actively engaged in basic and clinical research as well as in clinical management of patients with breast cancer, will again present the latest data, critically reviewed by leading specialists in the field. The conference closes as usual with an update of the widely acknowledged «St. Gallen International Consensus on the primary treatment of individuals with early breast cancer», which will be published only a few months after the conference.

We all look very much forward to be connected again with each other and to meet in Vienna. We are happy to draw your attention to the timeline right here:

Friday, 16 December 2022
Poster abstract submission deadline

Friday, 16 December 2022
Early registration deadline

Tuesday, 28 February 2023
Regular registration deadline

Wednesday, 1 March 2023
Late registration fee applies

 

We are looking forward to meet many professionals in person again and will very much enjoy meeting old and new friends. For those professionals who will not be able to travel, we will have the possibility to access a virtual platform, with live streaming of all sessions and entry to a virtual exhibition.

Stay tuned and register below for the newsletter of the St.Gallen International Breast Conference 2023 or join us social media!

facebook linkedin twitter

 

Your SGBCC 2023 Organising Team

St.Gallen Oncology Conferences
Rorschacherstrasse 150, 9006 St.Gallen/Switzerland
sgbcc@oncoconferences.ch
www.sg-bcc.org

conference programme

 

Understanding breast cancer complexity to improve patients outcomes

 

The 18th St.Gallen International Breast Cancer Conference 2023 will merge the best of the last conferences and is offering an innovative programme with a number of interactive sessions to allow for greater exchange between faculty and audiences.

Take a glance at the new programme to see what awaits you at next year’s conference and make sure to not miss any of the exciting themes!

 

quick-links

> Wednesday, 15 March 2023

> Thursday, 16 March 2023

> Friday, 17 March 2023

> Saturday, 18 March 2023

 

 
> Wednesday, 15 March 2023

 

08.30 - 09.30

Industry sponsored symposium

10.00 - 11.00

Industry sponsored symposium

11.30 - 12.30

Industry sponsored symposium

13.00 - 14.00

Opening and award ceremony

14.00 - 14.15

Short break

14.15 - 15.30

Session 1: News in breast cancer care since SGBCC 2021

Chairs: Beat Thürlimann (Switzerland)

15 min. per lecture
  • Surgery of patients with early breast cancer: Quo vadis? (Walter Weber, Switzerland)
  • Access to evidence based radiation therapy for patients with early breast cancer (Philip Poortmans, Belgium)
  • What’s new in systemic treatment of patients with early breast cancer (tbc)
  • Translational research priorities for patients with early breast cancer (Fabrice André, France)
  • Hot topics in survivorship, patient reported outcomes, and Quality of Life (Ann Partridge, USA)
15.30 - 16.00

Coffee break

15.30 - 16.15

SGBCC Academy

The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world. 

Chair: Emiel Rutgers (Netherlands)
Co-Chair: Sara Brucker (Germany)
Discussants: Meteb Al-Foheidi (KSA), Stefan Aebi (Switzerland), Zefei Jiang (China)

16.00 - 17.30

Interactive Session I: How to avoid unnecessary mastectomies and unnecessary reconstructions – a global discussion

Chairs: Monica Morrow (USA), Walter Weber (Switzerland)
Panelists: Meteb Al-Foheidi (KSA), Denisse Bretel (Peru), Jana de Boniface (Sweden), Fatima Cardoso (Portugal), Heba Gamal (Egypt), Eun-Sook Lee (Korea), Monica Morrow (USA), Lori Pierce (USA), Zhiming Shao (China), Tanja Spanic (Slovenia), Masakazu Toi (Japan)

17.30 - 19.00

Welcome Apéro at the Austria Center Vienna

 

> back to top

 
> Thursday, 16 March 2023
08.00 - 08.45

Industry sponsored symposium

09.00 - 10.00

Session 2: Genomics, Transcriptomics, ctDNA for disease monitoring and risk stratification

Chairs: Fabrice André (France), Meredith Regan (USA)

15 min. per lecture
  • ctDNA dynamics for early assessment of recurrence risk (Nicholas Turner, UK)
  • Molecular imaging in breast cancer (Elisabeth G. E. de Vries, Netherlands)
  • Multi-omic machine learning prediction of treatment response (Carlos Caldas, Portugal)
  • How to assess clinical utility and clinical validity of biomarkers in clinical trials? (Meredith Regan, USA)
10.00 - 11.00

Session 3: Immunology in early breast cancer

Chairs: Sherene Loi (Australia), Aleix Prat (Spain)

15 min. per lecture
  • Understanding the anti-cancer immune response: Innate and adaptive responses to breast cancer cells (Sherene Loi, Australia)
  • Tumor microenvironment in early breast cancer (Carsten Denkert, Germany)
  • Multiplexed analysis and spatial histology to predict response (Marleen Kok, Netherlands)
  • The future of breast cancer immunotherapy (PD, PDL, vaccines) (Giuseppe Curigliano, Italy)
11.00 - 13.00

Lunch break

11.30 - 12.30

Industry sponsored symposium

12.45 - 13.30

Special lecture I and panel discussion

Chair: Michael Gnant (Austria)
Panelists: David Cameron (UK), Heba Gamal (Egypt), Chiun-Sheng Huang (Taiwan)

Special lecture I
The future of innovation: Why are we conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? (Sara Tolaney, USA)

 

13.30 - 14.30

Session 4: Hereditary Breast Cancer

Chairs: Lisa Carey (USA), Suzette Delaloge (France)

15 min. per lecture
  • Imaging, screening & surveillance for individuals with increased hereditary breast cancer risk (Suzette Delaloge, France)
  • Local treatment in patients with high risk hereditary breast cancer (Maria Joao Cardoso, Portugal)
  • Management of patients harboring medium penetrance genes (Christian Singer, Austria)
  • Adjuvant systemic therapy for patients with germline BRCA1/2 mutations (Andrew Tutt, UK)
14.30 - 15.30

Session 5: The future treatment landscape in the adjuvant setting

Chairs: Sibylle Loibl (Germany), Martine Piccart (Belgium)

15 min. per lecture
  • Post-neoadjuvant options in triple negative disease: PARPi, capecitabine, checkpoint inhibitors (Javier Cortes, Spain)
  • Risk assessment in ER positive disease: Who should receive CDK 4-6 inhibitors? (Angela De Michele, USA)
  • What’s next? Antibody drug conjugates for breast cancer therapy (Cristina Saura, Spain)
  • Integrating new oral SERDs in the adjuvant treatment (David Cameron, UK)
15.30 - 16.00

Coffee break

15.30 - 16.15

SGBCC Academy

The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world. 

Chair: Fatima Cardoso (Portugal)
Co-Chair: Carlos Barrios (Brazil)
Discussants: tbc

16.00 - 16.45

Debate I: Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)?

Chairs: Giuseppe Curigliano (Italy), Miguel Martin (Spain)
Debaters: Lisa Carey (USA), Nadia Harbeck (Germany)

16.45 - 17.30

Interactive Session II: Too big, too small? Too low, too high? Adjuvant choices when stage and biology do not align.

Chairs: Harold Burstein (USA), Prudence Francis (Australia)
What to do in discordant scenarios? Small tumors with high biological risk? (Case studies)

17.30 - 17.45

Short break

17.45 - 18.45

Industry sponsored symposium

 

> back to top

 
> Friday, 17 March 2023
08.00 - 08.45

Industry sponsored symposium

09.00 - 10.00

Session 6: Tailoring breast surgery and radiotherapy

Chairs: Jana de Boniface (Sweden), Lori Pierce (USA)

15 min. per lecture
  • Patient selection, dose and fractionation for external beam radiotherapy in patients with early breast cancer (Charlotte Coles, UK)
  • Benefits and risks of immediate breast reconstruction after tumorectomy or mastectomy (Marie-Jeanne Vrancken Peeters, Netherlands)
  • Breast surgery after neoadjuvant therapy (Andrea V. Barrio, USA)
  • Breast surgery for local recurrence (Isabel Rubio, Spain)
10.00 - 11.00

Session 7: Controversies in the treatment of the axilla

Chairs: Philip Poortmans (Belgium), Zhiming Shao (China)

15 min. per lecture
  • Should imaging-based staging of the axilla be standard care and what is the best imaging modality? (Jörg Heil, Germany)
  • Axillary surgery in the adjuvant setting (Jana de Boniface, Sweden)
  • Axillary surgery in the post-neoadjuvant setting (Oreste Gentilini, Italy)
  • De-escalation of axillary radiotherapy – the time has come! (Icro Meattini, Italy)
11.00 - 13.00

Lunch break

11.30 - 12.30

Industry sponsored symposium

13.00 - 13.45

Debate II: Axillary dissection versus axillary radiation for residual nodal disease

Chairs: Michal Gnant (Austria), Philip Poortmans (Belgium)
Debaters: Orit Kaidar-Person (Israel), Monica Morrow (USA) 

13.45 - 14.30

Interactive Session III: Controversies and uncertainties in axillary management

Chairs: Walter Weber (Switzerland), Bahadir Gulluoglu (Turkey)
Panelists: Jana de Boniface (Sweden), Oreste Gentilini (Italy), Orit Kaidar-Person (Israel), Eun-Sook Lee (Korea),  Monica Morrow (USA), Philip Poortmans (Belgium), Isabel Rubio (Spain)

14.30 - 14.45

Short break

14.30 - 15.15

SGBCC Academy

The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world. 

Chair: Elzbieta Senkus-Konefka (Poland)
Co-Chair: Miguel Martin (Spain)
Discussants: Chiun-Sheng Huang (Taiwan), Gerd Fastner (Austria), tbc

14.45 - 15.45

Session 8: Optimizing treatment in patients with HER2-positive breast cancer

Chairs: Hope S. Rugo (USA), tbc

15 min. per lecture
  • Assessing HER2 heterogeneity (Frederique Penault-Llorca, France)
  • Current adjuvant and neoadjuvant approaches (Nadia Harbeck, Germany)
  • Emerging new treatments in HER2 positive breast cancer (Martine Piccart, Belgium)
  • ER positive vs ER negative: tackling diversity in HER2 positive breast cancer (Aleix Prat, Spain)
15.45 - 16.45

Session 9: Optimizing treatment in patients with triple negative breast cancer

Chairs: Lisa Carey (USA), Zefei Jiang (China)

15 min. per lecture
  • Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer (Hope S. Rugo, USA)
  • Optimal systemic therapy for residual disease in TNBC (tbc)
  • Tackling triple negative histological subtypes in early breast cancer (Jorge Reis Filho, USA)
  • Can we de-escalate immunotherapy and chemotherapy in TNBC? (Hervè Bonnefoi, France)
16.45 - 17.30

Debate III: If you achieve pCR after neoadjuvant, do you need adjuvant therapy?

Chairs: Eric Winer (USA), tbc
Debaters: Sibylle Loibl (Germany), Steven Chia (Canada)

17.30 - 17.45

Short break

17.45 - 18.45

Industry sponsored symposium

 

> back to top

 

> Saturday, 18 March 2023
08.00 - 08.45

Industry sponsored symposium

09.00 - 10.00

Session 10: Global Prespective on breast cancer treatment

Chairs: Carlos Barrios (Brazil), Binghe Xu (China)

15 min. per lecture
  • Breast cancer treatment and research from a global perspective (Benjamin Anderson, World Health Organization)
  • Perspective from Asia (Binghe Xu, China)
  • Perspective from Africa (Heba Gamal, Egypt)
  • Perspective from Latin America (Denisse Bretel, Peru)
10.00 - 11.00

Session 11: Optimizing treatment in patients with HR positive breast cancer

Chairs: Stefan Aebi (Switzerland), tbc

15 min. per lecture
  • Post-menopausal: Who needs chemotherapy in the neo (adjuvant) setting? (Steven Johnston, UK)
  • Pre-menopausal: Who needs chemotherapy in the (neo)adjuvant setting? (Prudence Francis, Australia)
  • Can we omit adjuvant endocrine therapy? (Fatima Cardoso, Portugal)
  • Duration of endocrine therapy in early breast cancer (Jens Huober, Switzerland)
11.00 - 11.15

Short break

11.15 - 11.45

Debate IV: Surgery of the primary for stage IV disease

Chairs: William Gradishar (USA), Bahadir Gulluoglu (Turkey)

Presenting data: William Gradishar (USA)
Debaters: Rajendra Badwe (India), Florian Fitzal (Austria)

11.45 - 12.00

Special lecture II

Pushing the boundaries for cure – extending early BC to oligometastatic? (David Cameron, UK)

12.00 - 12.30

Lunch break

12.30 - 14.30

St.Gallen International Consensus Session I

St.Gallen International Consensus Session on the primary treatment of patients with breast cancer 2023
Seeking consensus on evidence and opinions

Moderator and Scientific Secretary: Harold Burstein (USA), Giuseppe Curigliano (Italy)

14.30 - 14.45

Short break

14.45 - 16.45

St.Gallen International Consensus Session II

St.Gallen International Consensus Session on the primary treatment of patients with breast cancer 2023
Seeking consensus on evidence and opinions

Moderator and Scientific Secretary: Harold Burstein (USA), Giuseppe Curigliano (Italy)

16.45 - 17.00

Farewell

 

 

 

> back to top

SGBCC academy

The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world 

 

St.Gallen Oncology Conferences is renowned for their initiatives to foster research and education in early breast cancer care and the virtual SGBCC 2021 opened new doors to facilitate this mission.

As such we want to introduce the SGBCC Academy for our 2023 edition, which provides lectures on the most important topics in early breast cancer care, broken down by panellists of the St.Gallen Consensus as distinguished experts in the fields.

These will be available on-demand from 3 weeks before congress start and the congress will also feature daily SGBCC Academy sessions during which virtual and on-site participants will have the opportunity to directly ask follow-up questions on the presentation topics and further discuss the most pressing issues faced in client care by physicians around the world.

Featured topics for the 2023 edition will be:

  • Early Detection, Diagnosis of Breast Cancer, quality control and Public Health Aspects (Sara Brucker, Germany)
  • Breast Surgery Standards in 2023 (Emiel Rutgers, Netherlands)
  • Endocrine therapies in early breast cancer (Stefan Aebi, Switzerland)
  • Chemotherapy in early breast cancer – who benefits? (tbc)
  • State-of-the-art targeted therapies for early breast cancer (tbc)
  • Modern radiotherapy for early breast cancer (Gerd Fastner, Austria)
  • Overtreament in early breast cancer-who is at risk? (Elzbieta Senkus-Konefka, Poland)
  • New drugs on the horizon for early breast cancer (Miguel Martin, Spain)
  • Adequate treatment for early breast cancer in LMIC ? (Carlos Barrios, Brazil)
  • The importance of defining standards of care for breast cancer (Fatima Cardoso, Portugal)
  • Systemic therapy for the elderly (tbc)
  • Immunotherapy for early breast cancer – who benefits? (Meteb Al-Foheidi, KSA)
  • Luminal B-like cancers and neoadjuvant systemic therapy – who benefits? (tbc)
  • Preop MRI: helpful or dangerous for the breast surgeon? (Chiun-Sheng Huang, Taiwan)
  • Gene signatures – who benefits? (tbc)
  • CDK4/6 Inhibition in early breast cancer – who benefits? (Zefei Jiang, China)

registration

 

The 18th St.Gallen International Breast Cancer Conference 2023 will return to the Austria Center Vienna from 15 – 18 March 2023. We already look forward to meet many professionals in person again and will very much enjoy meeting old and new friends. For those professionals who will not be able to travel, we will have the possibility to access a virtual platform, with live streaming of all sessions and entry to a virtual exhibition.

> Register here and secure your early-bird ticket on a reduced starting fee!

 

Registration fees:

 Early-bird fee until
16 December 2022
Regular fee from
16 December 2022
Late fee from
1 March 2023
Regular participantEUR 790.00EUR 950.00EUR 1100.00
Trainee*EUR 480.00EUR 600.00EUR 720.00
Allied health care professionals*EUR 230.00 EUR 300.00EUR 370.00
Undergraduate students*EUR 230.00 EUR 300.00EUR 370.00
Patient advocates*EUR 230.00 EUR 300.00
EUR 370.00
Emerging economies*EUR 100.00EUR 100.00EUR 100.00
Pressfree registrationfree registrationfree registration

 

*Registration category definition:

TraineeThe trainee fee is only applicable for master and PhD students as well as for young physicians in training. A certificate from the supervisor or head of department is required.
Allied health care professionalsThe allied health professional fee applicable for professionals without a medical degree. A confirmation from the head of department is required. Allied Health Professionals include e.g. nutritionist, dieticians, psychologists, physiotherapists, and nurses
Undergraduate studentsThe undergraduate student fee is only applicable for medical students at university/college level who have not finished any medical degree yet. A certificate confirming the undergraduate student status required.
Patient advocatesBreast Cancer patients, individually or representing a patient advocacy group. A confirmation of the patient advocacy group may be requested.
Emerging economiesThe emerging economies fee applies to individuals from low and lower-middle-income economies according to the World Bank listing
(https://datahelpdesk.worldbank.org/knowledgebase/articles/906519)

 

The registration fee includes:

  • conference documentation
  • participation in the conference programme – scientific sessions and sponsored industry symposia
  • attendance at the opening ceremony & welcome apéro on 15 March 2023
  • admission to the industrial exhibition
  • coffee breaks
  • public transportation ticket (valid from 15 to 18 March 2023)
  • certificate of attendance upon submission of an online feedback questionnaire after the conference
  • free virtual access to live stream and on-demand videos of selected scientific sessions (on-demand recordings will be accessible for a limited time after the congress)

 

> Register now and be part of this unique experience!

 

Group registration

Group registration is possible if your company/institute invites several participants to SG-BCC 2023 and needs one collective invoice for the registrations.

If you would like to register a group of 10 or more delegates, please click on following link: https://mondial.eventsair.com/bcc2023/groupreg.

In case of any further questions please contact sgbcc@mondial-congress.com.

 

Official Italian Agency for AIFA Procedure

Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). 

The request of authorization must be submitted within 60 days before the starting date of the event.

Mondial Congress & Events advises pharmaceutical companies to contact the Official Agency:

Fargo International 
Contact: Benedetta Cambria
Via P.Maroncelli 27 – 50137 Firenze (Italy)
email: b.cambria@alifargoint.it
Tel +39 3203830442

 

Stay tuned and register below for the newsletter of the St.Gallen International Breast Conference 2023!

abstracts

 

St.Gallen Oncology Conferences has the mission to distribute the knowledge to improve quality care for individuals with early breast cancer worldwide. Your contribution can be a fundamental part of that claim. Do not hesitate and submit your abstract today!

Your abstract for the 18th St.Gallen International Breast Cancer Conference 2023 can be submitted here:

> abstract submission platform

Make sure to submit your work via our abstract submission platform until 16 December, 2022 the latest.

 

FAQ:

  1. Abstract structure:
    Goals, Methods, Results, Conclusions / Word/Character count: 2,500 characters / Max. number of tables: 3
  2. Are there any abstract restrictions? 
    Need to stand up with scientific rules and methods and to be original, presenting unpublished data.
    Poster-Abstract presenters are invited to present in Vienna.
  3. What is the meeting theme?
    Understanding breast cancer complexity to improve patient outcomes. See www.sg-bcc.org
  4. When do we receive an abstract notification (decision date)?
    This is January 26th 2023.  
  5. What is your late-breaker criteria? Do you accept late-breaking abstract submissions?
    This is a case by case decision. 
  6. Do you accept trials in progress?
    Generally yes, but need to describe underlying theory, research question, methods and, if available, preliminary data.
  7. Do you accept encore abstracts? If so, are there any restrictions?
    These are considered case by case.
  8. May I submit more than one abstract?
    Yes you may
  9. How many delegates are attending your congresses?
    Please find the numbers in total (3500) or % of oncologists, clinicians etc. as described in the Sponsorship Brochure www.sg-bcc.org
  10. Do you have regional breakdown of the type of delegates?
    Yes, please have a look in the Sponsorship Broschure at the website.
  11. For scientific/medical opportunities do you offer:
    Abstracts in Embase: yes
    Virtual Meeting: yes, but limited
    Abstracts in Web of Science: yes
  12. For commercial opportunities, do you offer:
    Affiliated events: yes (e.g. Satellite Symposia, IBCSG Annual Meeting, Best of St.Gallen Meetings)
    Meeting app: yes
    Symposia: yes
    Webcasts: yes
    Exhibitor/sponsorship opportunities: yes. Please consult the Sponsorship Broschure at the Website www.sg-bcc.org
  1.  

 

 

Stay tuned and register below for the newsletter of the St.Gallen International Breast Cancer Conference 2023 so you won’t miss the latest news.

chairs

 

Meet our chairs:

Conference co-chairs
Univ. Prof. Dr. Michael Gnant, Medical University of Vienna / Austria
Prof. Dr. med. Beat Thürlimann, Breast Centre, Kantonsspital St.Gallen / Switzerland
Prof. Dr. Walter Weber, University Hospital Basel / Switzerland

 

Conference founder and honorary chair
Prof. Dr. med. Hans-Joerg Senn, Foundation St.Gallen Oncology Conferences (SONK), St.Gallen / Switzerland

 

Scientific Programme-Chairpersons
Harold Burstein, Boston/MA, USA
Giuseppe Curigliano, Milano/Italy
Michael Gnant, Vienna/Austria
Philip Poortmans, Antwerp/Belgium
Meredith Regan, Boston/MA, USA
Hans-Jörg Senn, St.Gallen/Switzerland
Beat Thürlimann, St.Gallen/Switzerland
Walter Weber, Basel/Switzerland
Eric Winer, New Haven/CT, USA

press registrations

 

We are inviting members of the press to join us for the virtual SGBCC 2023 and offer free press registrations for them to cover the event.

 

Registration as press member

For press registration please fill out the online registration form and select “press” for registration type. In case there are any questions contact Mondial Congress & Events, sgbcc@mondial-congress.com

 

Press Office

The Conference Secretariat offers journalists full support throughout the meeting. All registered journalists can arrange interviews with physicians and researchers who present their work during the 18th St.Gallen International Breast Cancer Conference. For support arranging an interview, please contact sgbcc@mondial-congress.com outlining the requested interviewee(s), the scope of the interview and availabilities.

 

Media policies

  • Only registered journalists who provided their press credentials prior to the meeting will gain online access. Press registrations are non-transferable.
  • Registration is limited to a maximum of three representatives per media outlet.
  • Financial analysts, sales, advertising, marketing and public relations personnel may not register as press.
  • It is not permitted to record/screen grab any of the official scientific sessions. The use of the St.Gallen International Breast Cancer Conference logo is only allowed with prior written permission of the SONK. It can be requested from the SONK Secretariat.

 

Copyright of presentation material

  • All materials in written or illustrated form presented in the scientific programme are the intellectual property of the authors and all rights reside with them. Recording without proper authorisation by the holder of rights must be considered a violation of copyrights and will be prevented by the organisers of the conference.

 

Embargo breaks for media reporters

Breaking of the embargo policy by a reporter will lead to one or more of the following measures:

  • Immediate suspension of the reporter’s media conference credentials
  • Immediate barring of the reporter and all other members of his/her media outlet from the meeting platform
  • No access to the next meetings for representatives of the media outlet

accommodation

 

Every spring, Vienna is bustling with congress and exhibition attendees and visitors for business and pleasure. Take advantage of the attractive hotel booking fees for the best picks in terms of price, comfort and location.

Please find the list of hotels here: SGBCC 2023 Hotel Overview

Availability, especially in on-site hotels, is limited. Make sure you secure a room as soon as possible. The official travel and housing agent for SGBCC 2023 is Mondial Congress & Events. During the registration process you are able to book a hotel room nearby the conference venue.

If you have any specific queries with regard to your booking, please contact:

Mondial Congress & Events Mondial GmbH & Co. KG
Lea Hofer
T office +43 1 58804-228
T mobile +43 676 845 880 701
l.hofer@mondial-congress.com

 

Warning – accommodation scam alert!

There are an increasing number of fraudulent websites and agencies that impersonate SGBCC 2023.

We would like to alert all participants to be aware of possible scams and to strongly advise you to only use the official SGBCC 2023 Website https://www.oncoconferences.ch/events/sg-bcc-2023/ as well as the official SGBCC 2023 accommodation agency Mondial Congress & Events.

Any other companies are in no way connected with Mondial Congress & Events and SGBCC 2023 and we therefore cannot vouch for the services they are offering. We strongly advise you not to share any credit card details with them.

Unfortunately, these fraudulent websites cannot be prevented and we sincerely regret any inconvenience. If you have any further questions, please don’t hesitate to contact us.

 

exhibition & sponsorship opportunities

 

Next year’s conference will merge the best of the last conferences – the 18th St.Gallen International Breast Cancer Conference is offering an innovative programme with a number of interactive sessions to allow for greater exchange between the faculty and audiences – it will give your company numerous opportunities to reach the community!

On the back of our successful virtual St.Gallen International Breast Cancer Conference 2021, we’ve decided that the 18th edition will increase accessibility and interactivity to further increase the outreach and educational mission of the Foundation SONK. For those professionals who will not be able to travel, we will have the possibility to access a virtual platform, with live streaming of all sessions and entry to a virtual exhibition.

Quicklinks

  1. SGBCC 2023 Sponsorship Opportunities
  2. Online application for exhibition and sponsorship
  3. Exhibition Package
  4. Satellite Symposia
  5. Other Sponsorship Opportunities
  6. Contact

 

1. SGBCC 2023 Sponsorship Opportunities

Find all our exciting exhibition and sponsorship opportunities in the brochure:

> SGBCC 2023 Sponsorship Opportunities

> back to top

2. Online application for exhibition and sponsorship

To sign up for exhibition and sponsorship, you have to complete the online exhibition and sponsorship application form via the following link:

> Online application for exhibition and sponsorship

By completing the exhibition application form, companies agree to the SGBCC 2023 Sponsorship & Exhibition Terms & Conditions. The booking is legally binding upon submission.

> back to top

Below you can find a summarized but not exhaustive sponsorship opportunity list from our brochure.

3. Exhibition Package (min. 6 sqm)

Early-bird fee until Tuesday, 6 September 2022: € 550/ m2
Regular fee from Wednesday 7, September 2022: € 600/m2

Space allocation procedure will start in summer 2022 and will be done according to the following guidelines: total sponsorship contribution, booth size, date of application and payment of first deposit.

> back to top

4. Satellite Symposia

Wednesday, 15 March 2023 | 08:30-09:30€ 90,000 
Wednesday, 15 March 2023 | 10:00-11:00€ 90,000 
Wednesday, 15 March 2023 | 11:30-12:30€ 110,000sold
Thursday, 16 March 2023 | 08:00-08:45€ 90,000sold
Thursday, 16 March 2023 | 11:30-12:30€ 110,000sold
Thursday, 16 March 2023 | 17:45-18:45€ 100,000sold
Friday, 17 March 2023 | 08:00-08:45€ 90,000 
Friday, 17 March 2023 | 11:30-12:30€ 110,000sold
Friday, 17 March 2023 | 17:45-18:45€ 100,000sold

 

Complete the Online Exhibition and Sponsorship Application to reserve your preferred time slot. Bookings must be submitted and will only be accepted via the online application. No options can be reserved. More details an information in the SGBCC 2023 industry brochure above.

Included benefits:

  • Use of the main auditorium
  • Broadcast of the live Satellite Symposia on the Virtual Platform
  • Publication of symposium programme
  • One push notification
  • One mailing sent to all registered participants
  • 10% discount on the exhibition space
  • 5 Full conference registrations

More details and information can be found in the SGBCC 2023 industry brochure above.

> back to top

5. Many other sponsorship opportunities

  • e-poster area
  • Water dispensers
  • Sitting cubes
  • Digital advert on the virtual conference platform
  • Video advertising spot
  • Mailing to participants
  • Article in the SG-BCC newsletters

More details and information can be found in the SGBCC 2023 industry brochure above.

> back to top

6. Contact

If you have any questions please get in contact with:

Ellen Valckenaere
Senior Industry Relations Manager
Mondial Congress & Events
valckenaere@mondial-congress.com

> back to top

contact

 

St. Gallen Oncology Conferences (SONK)
Rorschacherstrasse 150
9006 St.Gallen / Switzerland
+41 71 243 09 90
sgbcc@oncoconferences.ch

newsletter

 

Stay tuned and register now for the newsletter of the St.Gallen International Breast Conference 2023 or join us on social media! 

facebook linkedin twitter

webcasts

Click on the links below to view the webcasts of the St.Gallen International Breast Cancer Conferences of the previous years:

register here

Newsletter abonnieren